Is XERS A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) is a good investment right now. We like to check what the smart money thinks first before...
Xeris Pharmaceuticals Inc (XERS)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tamarack Capital Management Justin John Ferayorni | 350,000 | $1,579 | 0.32% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.06 | 10,000 | Officer, Director | 411,134 | 2020-12-09 | Filing | |
| $3.55 | 22,000 | Officer | 117,493 | 2020-05-13 | Filing | |
| $3.20 | 7,886 | Officer | 95,493 | 2020-05-08 | Filing | |
| $3.00 | 33,000 | Officer, Director | 401,134 | 2020-05-08 | Filing | |
| $1.97 | 4,000 | Officer | 57,083 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.07 | 10,000 | Officer | 496,824 | 2021-04-12 | Filing | |
| $6.01 | 10,000 | Officer | 406,824 | 2021-01-13 | Filing | |
| $5.72 | 10,000 | Officer | 416,824 | 2021-01-11 | Filing | |
| $5.50 | 10,000 | Officer | 421,824 | 2020-01-13 | Filing | |
| $7.97 | 10,000 | Officer | 449,324 | 2019-10-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 12,550 | $57,000 | 0% | |
| 2. | 6,000 | $27,060 | 0% | |
| 3. | 3,764,948 | $16,981 | 0% | |
| 4. | 785,701 | $3,543 | 0% | |
| 5. | 757,400 | $3,416 | 0% |
News See All
Hedge Funds Are Crazy About Xeris Pharmaceuticals, Inc. (XERS)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings...
Hedge Funds Have Never Been This Bullish On Xeris Pharmaceuticals, Inc. (XERS)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful...
Hedge Funds Are Selling Xeris Pharmaceuticals, Inc. (XERS)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards...
Is Xeris Pharmaceuticals, Inc. (XERS) A Good Stock To Buy?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors...
Hedge Fund and Insider Trading News: Ray Dalio, Nelson Peltz, Weight Watchers International, Inc. (WTW), Xeris Pharmaceuticals Inc (XERS), Carolina Financial Corporation (CARO), and More
Hedge fund legend Ray Dalio, who runs Bridgewater Associates, is widely considered to be one of the most successful hedge fund managers in the world. Dalio has $18.4 billion in net worth, the second richest...
Hedge Fund and Insider Trading News: Carl Icahn, SkyBridge Capital, Xeris Pharmaceuticals Inc (XERS), Legacy Reserves LP Unit (LGCY), Pershing Gold Corp (PGLC), and More
(Reuters) - Activist investor Carl Icahn boosted his stake in Energen Corp (EGN.N), a filing showed on Tuesday, as he eyes a potential takeover of the oil and gas producer. In May, hedge fund manager...
Billionaire Hedge Funds
